Scanderia Venture, established in 2018, is a venture capital firm based in Białystok, Poland, with an additional office in Warsaw. The firm focuses on supporting pre-seed and seed-stage startups operating in the life sciences, medtech, healthcare, ICT, and biomedical engineering sectors. Scanderia Venture offers both financial and expert support to innovative projects, aiming to foster their development and commercialization. The firm has been involved in the BRIdge Alfa Program, a Polish initiative supporting R&D projects, and has invested in various startups, including JustBee, ProSpeed Energy, AlterBioTech, GraftFlow, Navimed, and Miodajnik.
Is Scanderia Venture the right investor for your startup? Browse their investment focus, stage preferences, and geographic scope to see how well they align with your fundraising goals. Your full match score with Scanderia Venture, along with a list of other relevant VCs, is available on Hopohopo.io.
Stages
Pre-seed, Seed
First ticket size
PLN 100,000 - PLN 1,500,000
When approaching Scanderia Venture, founders should highlight the scientific rigor and commercialization potential of their technology, especially if it addresses unmet needs in healthcare or biomedical engineering. Demonstrating a clear path from R&D to market adoption, with early validation or traction, will resonate well. Emphasize how your team’s expertise and vision align with navigating regulatory and clinical milestones, as Scanderia values founders who can bridge technical innovation with real-world impact.
Stop wasting weeks searching for the right investors. Upload your deck and get matched with investors who actually fit your startup — so you can focus on building, not chasing.